Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)
Dariusz Dudek1*, MD, PhD; Roxana Mehran2,3, MD; Artur Dziewierz1, MD, PhD; Sorin J. Brener3,4, MD; Tomasz Rakowski1, MD, PhD; Michał Brzeziński1, MD; Bruce R. Brodie5, MD; Ke Xu3, PhD; Martin Fahy3, MSc; Alexandra J. Lansky6, MD; Krzysztof Żmudka1, MD, PhD; Gregg W. Stone3,7, MD
1. Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland; 2. Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3. Cardiovascular Research Foundation, New York, NY, USA; 4. New York Me
Aims: Using the database from the large-scale, prospective, randomised HORIZONS-AMI trial, the authors sought to assess the impact of bifurcatio
